Clinical Trial Update: A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients [Phase 3]

View source ↗

Summary

Phase 3 trial comparing HD204 to Avastin in advanced non-squamous non-small cell lung cancer is active but not recruiting, evaluating efficacy, safety, pharmaco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Avastin (bevacizumab)
• HD204

Snippet

Sponsor: Prestige Biopharma Limited | Conditions: Lung Cancer, Non-small Cell Lung Cancer | Phase 3 | Status: ACTIVE_NOT_RECRUITING